Paclitaxel Injections IP 260 mg

Product Description

Paclitaxel injection is a chemotherapy drug used to treat various types of cancer, including breast, ovarian, lung, and bladder cancer. It is a type of chemotherapy drug known as a taxane, which works by interfering with the growth of cancer cells. Paclitaxel injection is given intravenously (into a vein) by a healthcare professional. Common side effects include nausea, vomiting, constipation, hair loss, and decreased white blood cell counts.

Effective Therapy for Various Cancers

Paclitaxel Injection IP 260 mg is indicated for the treatment of several malignancies, including ovarian, breast, and lung cancers, as well as Kaposis sarcoma. Its proven efficacy and regulatory approval in India make it a reliable choice for oncologists managing these complex conditions. The medication disrupts cell division, targeting cancer cells effectively during therapy.


Safe Administration and Handling

This cytotoxic drug is formulated as a clear, colorless to pale yellow sterile solution, supplied in single-dose vials for intravenous use only. It must be administered and handled exclusively by trained oncology professionals under medical supervision. Proper administration and adherence to safety protocols ensure both patient benefit and healthcare worker safety.


Storage and Compatibility

To maintain effectiveness and safety, Paclitaxel Injection must be stored below 25C, protected from light, and never frozen. The formulation is compatible with both saline and dextrose infusion fluids, offering flexibility in clinical settings. Batch and expiry details are clearly indicated on the vial label for user reference.